1653 related articles for article (PubMed ID: 18661411)
21. Two cases of recurrent IgA nephropathy following kidney transplantation.
Kishi Y; Takai K; Akao J; Isoyama N; Matsumura M; Uchiyama K; Tsuchida M; Suga A; Naito K
Transplant Proc; 2004 Sep; 36(7):2160-1. PubMed ID: 15518785
[TBL] [Abstract][Full Text] [Related]
22. Clinical remission and pathological progression after tonsillectomy in a renal transplant patient with recurrent IgA nephropathy.
Sakai K; Saneshige M; Takasu J; Yanagisawa T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
Clin Transplant; 2009 Aug; 23 Suppl 20():44-8. PubMed ID: 19594596
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and natural history of IgA nephropathy.
Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
[TBL] [Abstract][Full Text] [Related]
24. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
25. Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome.
Vallejos A; Alperovich G; Moreso F; Cañas C; de Lama ME; Gomà M; Fulladosa X; Carrera M; Hueso M; Grinyó JM; Serón D
Nephrol Dial Transplant; 2005 Nov; 20(11):2511-6. PubMed ID: 16077142
[TBL] [Abstract][Full Text] [Related]
26. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
Espinosa M; Ortega R; Gómez-Carrasco JM; López-Rubio F; López-Andreu M; López-Oliva MO; Aljama P
Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
[TBL] [Abstract][Full Text] [Related]
27. [Primary IgA mesangial nephropathy (Berger's disease): clinico-pathological study].
Nussenzveig I; Saldanha LB; Marcondes M
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(1):7-20. PubMed ID: 2814190
[TBL] [Abstract][Full Text] [Related]
28. Factors predicting progression of IgA nephropathies.
Coppo R; D'Amico G
J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
31. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
Boratyńska M; Banasik M; Watorek E; Falkiewicz K; Patrzałek D; Szyber P; Klinger M
Transplant Proc; 2006; 38(1):101-4. PubMed ID: 16504675
[TBL] [Abstract][Full Text] [Related]
32. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.
Chan GS; Lam MF; Au WY; Chim S; Tse KC; Lo SH; Fung SH; Lai KN; Chan KW
Nephrology (Carlton); 2008 Jun; 13(4):322-30. PubMed ID: 18221254
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation.
Ushigome H; Suzuki T; Fujiki M; Nobori S; Sakamoto S; Okamoto M; Urasaki K; Yoshimura N
Clin Transplant; 2009 Aug; 23 Suppl 20():17-22. PubMed ID: 19594590
[TBL] [Abstract][Full Text] [Related]
35. Proteinuria after conversion to sirolimus in renal transplant recipients.
Sahin GM; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
[TBL] [Abstract][Full Text] [Related]
36. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
Ortiz F; Gelpi R; Koskinen P; Manonelles A; Räisänen-Sokolowski A; Carrera M; Honkanen E; Grinyó JM; Cruzado JM
Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
[TBL] [Abstract][Full Text] [Related]
37. [Risk factors affecting the long-term outcome of IgA nephropathy].
Yang NS; Wu QQ; Du Y; Zhang R; Li YJ; Ye RG; Yu XQ
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
[TBL] [Abstract][Full Text] [Related]
38. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
Ibels LS; Györy AZ
Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
[TBL] [Abstract][Full Text] [Related]
39. Acute renal failure in IgA nephropathy: aggravation by gross hematuria due to anticoagulant treatment.
August C; Atzeni A; Köster L; Heidenreich S; Lang D
J Nephrol; 2002; 15(6):709-12. PubMed ID: 12495289
[TBL] [Abstract][Full Text] [Related]
40. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
